GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,520 | +33.3% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $80,640 | -31.4% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $117,600 | +300.3% | 56,000 | +115.4% | 0.00% | – |
| Q4 2022 | $29,380 | -30.0% | 26,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $42,000 | +23.5% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,000 | -19.0% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $42,000 | -16.0% | 26,000 | +8.3% | 0.00% | 0.0% |
| Q4 2021 | $50,000 | -46.2% | 24,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $93,000 | +20.8% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $77,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |